G1GLP1 Note Country US

HomeCoverageGLP-1US

CoverageUS · Checked · Rechecked monthly

GLP-1 Without Insurance: Costs and Which Weight Loss Drugs Insurance Covers

In 2026 a GLP-1 weight loss drug without insurance costs $149 to $449 a month when you buy direct from the maker. If your plan covers the drug, a savings card can bring it down to $25, and the Medicare GLP-1 Bridge charges $50. Pick your situation to see the lowest price open to you.

Which one is you?

With the Wegovy or Zepbound savings card

$25a month at best

Most the Wegovy card saves per month$100

Most the Zepbound card saves per month$100

Zepbound card expiresDec 31, 2026

From the manufacturers' and Medicare's published terms. Eligibility rules apply.

Want every drug side by side with its monthly price?

See the monthly price of each GLP-1 in the US

List price and self-pay price, drug by drug.

No insuranceCovered drugsSavings cardsMedicarePay lessFAQ

GLP-1 without insurance

Without insurance, the lowest prices come from the makers' own self-pay programs. A month of pills starts at $149 and a month of injections starts at $299.

Self-pay is a cash purchase. It does not go through your plan, so the money does not count toward your deductible or out-of-pocket limit.

Monthly cost without insurance, bought direct from the maker

Wegovy pill$149 · $199 · $299 by dose

Wegovy pen$349 · $399 for the 7.2 mg HD pen

Zepbound vial or KwikPen$299 · $399 · $449 by dose

Foundayo pill$149 – $299 by dose

Wegovy list price$1,349Wegovy pen self-pay$349Zepbound self-pay$299 – $449

New Wegovy patients can get the first two months of the 0.25 mg and 0.5 mg pens for $199 a month. That offer runs through December 31, 2026.

The Zepbound $449 price needs a reorder within 45 days of your last delivery. After that, 7.5 mg is $499 and 10, 12.5 or 15 mg is $699.

Zepbound prices change with each dose step.

See Zepbound prices by dose and its savings card

Wegovy prices and its card are in Wegovy coupon and savings card.

Weight loss drugs covered by insurance

There is no national rule in the US. Employer plans and marketplace plans each decide whether to cover weight loss drugs.

Plans that do cover them usually ask for prior authorization. Your prescriber sends your BMI and health history before the plan pays.

FDA approval for weight loss covers adults with a BMI of 30 or more, or 27 or more with at least one weight-related condition. A plan can add its own rules on top.

GLP-1 drugs approved for weight loss in the US

Wegovy (semaglutide)Injection approved June 4, 2021; pill December 22, 2025

Zepbound (tirzepatide)Approved November 8, 2023

Saxenda (liraglutide)Approved December 23, 2014

Foundayo (orforglipron) pillApproved April 1, 2026

Ozempic and Mounjaro are type 2 diabetes drugs, and plans often cover them for diabetes. Their card rules are in Ozempic coupon and copay card and Mounjaro coupon.

Zepbound is also approved for moderate to severe obstructive sleep apnea in adults with obesity, and plans often treat that use separately from weight loss.

1Check your planCall the number on your insurance card and ask whether your plan covers weight loss drugs and which ones.

2Ask for prior authorizationYour prescriber sends your BMI and health history to the plan.

3If it is coveredSign up for the maker's savings card to cut your copay.

4If it is not coveredUse the self-pay price from the table above.

If your copay is higher than the self-pay price, you can pay yourself instead. That money will not count toward your deductible.

Weight loss drug savings cards

A savings card is a copay discount from the drug maker. It saves the most when you have commercial insurance, the kind from an employer or a marketplace plan, and the plan covers the drug.

Savings cards compared, when your commercial plan covers the drug

Wegovy cardAs low as $25 · up to $100 off a month

Zepbound cardAs low as $25 · up to $100 off a month · $1,300 a year · 13 fills

You only reach $25 when your copay is low enough. With a $150 copay, a $100 card leaves you paying $50.

You cannot use these cards if you have Medicare, Medicaid, TRICARE, VA or another government plan, even if that plan does not cover the drug.

The Zepbound card ends on December 31, 2026. The maker can change or end any card, so check the dates when you sign up.

Medicare and weight loss drugs

Standard Medicare Part D does not cover GLP-1 drugs for weight loss alone. Two other doors are open in 2026.

Medicare GLP-1 Bridge

A temporary program that runs from July 1, 2026 to December 31, 2027. If you qualify, you pay $50 for a one-month supply. It lists Wegovy pens and pills, Foundayo and the Zepbound KwikPen.

When the drug is for another use

If the drug is prescribed for type 2 diabetes, sleep apnea or to lower the risk of heart attack and stroke, the claim goes to your Part D plan, not the Bridge. Each plan sets its own rules and copay.

The Bridge is open to people 18 or older who meet one of these three rules.

Who qualifies for the Medicare GLP-1 Bridge

BMI 35 or higherNo other condition needed

BMI 30 or higherPlus heart failure (HFpEF), high blood pressure not controlled on two medicines, or chronic kidney disease stage 3a or worse

BMI 27 or higherPlus prediabetes, a past heart attack or stroke, or peripheral artery disease with symptoms

People with type 2 diabetes, moderate to severe sleep apnea or noncirrhotic MASH are not part of the Bridge, even with a qualifying BMI.

The pharmacy submits the claim first and requests prior authorization. CMS usually decides within 72 hours. There is no appeal, but your prescriber can resubmit a corrected form.

The $50 does not count toward your deductible or out-of-pocket limit, and pen needles are not covered by the Bridge.

Medicaid differs by state. Whether it pays for weight loss drugs depends on your state's Medicaid drug list. A voluntary federal model called BALANCE lets states join, but it is not automatic nationwide.

If you are on Medicare, start with the drug you plan to use. Active ingredient, schedule and approved use for each one are in GLP-1 drugs explained.

How to pay less for GLP-1 without insurance

Start with the cheapest option. Pills begin at $149, which is less than any injection, but the price steps up with the dose.

The government site TrumpRx.gov lists the Wegovy pen, the Wegovy pill and Zepbound vials. The order runs through the maker's program.

Some self-pay offers exclude people with government insurance, so read the eligibility terms when you order.

Fill your prescription at a state-licensed pharmacy. The FDA lists online pharmacies that sell without a prescription as a warning sign.

Self-pay prices are monthly, so the total grows the longer you stay on the drug. A calculator shows the cost for the months you plan to use.

You can work out the total for a full course before you start.

Calculate your total GLP-1 cost

Pick a drug and dose to see the monthly total.

GLP-1 insurance FAQ

Does insurance cover weight loss drugs?

It depends on your plan. Many plans that do cover them require prior authorization. Call the number on your insurance card and ask about your plan's drug list.

How much is a GLP-1 a month without insurance?

It runs $149 to $449 with the makers' self-pay programs. The Wegovy pen is $349 and Zepbound is $299 to $449. Wegovy's list price is $1,349.02.

Does Medicare cover Wegovy or Zepbound?

Standard Part D does not cover them for weight loss. The Medicare GLP-1 Bridge gives eligible people a $50 month through December 31, 2027.

Can I use a savings card without insurance?

No. The Wegovy and Zepbound cards need commercial insurance. With no insurance, self-pay is the lowest price the makers offer.

Is there a generic GLP-1?

For weight loss there is one: FDA approved Teva's liraglutide generic of Saxenda on August 27, 2025. The details are in generic GLP-1 drugs.

Keep reading

GLP-1 cost in the US: the cheapest options by monthly price

Wegovy coupon and savings card

Zepbound savings card

Mounjaro coupon

Weight loss injections on the NHS

New weight loss drugs 2026

GLP1 Note rechecks the terms and prices on this page every month against the manufacturer and Medicare pages. See how we check prices.

Update log

: First published.

Sources

Eli Lilly, Zepbound coverage and savings; LillyDirect Zepbound and Foundayo self-pay terms.

Novo Nordisk, NovoCare Wegovy list price and savings.

CMS, Medicare GLP-1 Bridge information for providers and BALANCE model.

FDA, 2025 first generic drug approvals; How to buy medicines safely from an online pharmacy.

TrumpRx.gov, Zepbound listing.

GLP1 Note is an independent information site and does not sell medicines. Program terms can change, so check the official page when you sign up.